We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNTR
376
DELISTED
Venator Materials PLC
VNTR
| $23.8M | 0.05% |
7,182,957
-973,245
| -12% | -$2.32M |
|
377
Realty Income
O
$58.2B
| $23.8M | 0.05% |
394,327
+1,651
| +0.4% | +$97.6K |
|
|
ISBC
378
DELISTED
Investors Bancorp, Inc.
ISBC
| $23.7M | 0.05% |
2,244,616
+1,494,616
| +199% | +$13.7M |
|
379
Spyre Therapeutics
SYRE
$9.12B
| $23.5M | 0.05% |
119,680
| – | – |
|
380
Lennar Class A
LEN
$20.4B
| $23.4M | 0.05% |
316,529
-1,549
| -0.5% | -$116K |
|
381
Adient
ADNT
$1.48B
| $23.3M | 0.05% |
669,761
-1,117,770
| -63% | -$31.5M |
|
382
Skyworks Solutions
SWKS
$10.1B
| $23.3M | 0.05% |
152,150
+7,300
| +5% | +$1.07M |
|
383
Protagonist Therapeutics
PTGX
$9.4B
| $23.2M | 0.05% |
1,150,045
-1,370,555
| -54% | -$29.5M |
|
384
CBRE Group
CBRE
$42.7B
| $23.2M | 0.05% |
369,200
-3,200
| -0.9% | -$181K |
|
385
Amalgamated Financial
AMAL
$1.5B
| $23.1M | 0.05% |
1,681,660
+54,015
| +3% | +$687K |
|
386
Aflac
AFL
$64.5B
| $23.1M | 0.05% |
518,774
-219,200
| -30% | -$8.97M |
|
387
Ultragenyx Pharmaceutical
RARE
$2.54B
| $22.9M | 0.05% |
+165,500
| New | +$19.6M |
|
388
Mettler-Toledo International
MTD
$28.5B
| $22.7M | 0.05% |
19,909
-6,945
| -26% | -$7.62M |
|
389
Praxis Precision Medicines
PRAX
$10.3B
| $22.7M | 0.05% |
+27,472
| New | +$16M |
|
390
Entergy
ETR
$49.7B
| $22.7M | 0.05% |
453,804
+18,302
| +4% | +$963K |
|
391
Avnet
AVT
$7.94B
| $22.6M | 0.05% |
+645,000
| New | +$19.1M |
|
|
AMK
392
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $22.1M | 0.05% |
914,986
-7,806
| -0.8% | -$185K |
|
|
SIVB
393
DELISTED
SVB Financial Group
SIVB
| $21.9M | 0.05% |
56,438
-22,462
| -28% | -$7.28M |
|
|
AY
394
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $21.8M | 0.05% |
+575,000
| New | +$19M |
|
395
ProPetro Holding
PUMP
$1.34B
| $21.8M | 0.05% |
2,944,781
+1,613,939
| +121% | +$8.98M |
|
396
Las Vegas Sands
LVS
$29.9B
| $21.8M | 0.05% |
365,000
-1,600
| -0.4% | -$85.3K |
|
397
RenaissanceRe
RNR
$13.4B
| $21.6M | 0.05% |
+130,000
| New | +$22.1M |
|
|
CRHC.U
398
DELISTED
Cohn Robbins Holdings Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CRHC.U
| $21.5M | 0.05% |
2,000,000
| – | – |
|
|
LOKB.U
399
DELISTED
Live Oak Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-th
LOKB.U
| $21.5M | 0.05% |
+1,980,000
| New | +$20.7M |
|
400
Labcorp
LH
$25.6B
| $21.5M | 0.05% |
122,802
-4,889
| -4% | -$844K |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.